Search

Largemouth bass (Micropterus salmoides, LB) is an important aquaculture and fishing species in the world. LB has been introduced into China since 1983, and its aquaculture production has increased year by year. The total yield of LB in China reached 802,486 tons in 2022, ranking seventh in China's freshwater fish aquaculture. However, the LB is facing threats such as degradation of germplasm resources and disease susceptibility due to limitations in the scale of introduction, coupled with the effects of high-density aquaculture, inbreeding, and species hybridization. This paper summarizes the current status of LB germplasm resources, variety genetic improvement, nutrition and fodder, aquaculture mode and diseases, and circulation and processing. This paper also provides recommendations on how to fully explore and utilize the existing germplasm resources of LB; culture new LB germplasm that combines excellent resistance and growth characteristics through innovations in breeding techniques; reduce the morbidity rate and improve the efficiency of cultured LB through the optimization of fodder formulations and innovation of aquaculture modes; and shift the processing of LB toward standardization, efficient nutrition and safety through the integration of high-tech and large-scale production. This paper provides a reference for the sustainable and healthy development of the LB industry. [ABSTRACT FROM AUTHOR]

The use of doxorubicin (Dox) was severely constrained by dose-dependent side effects, which might be attenuated by combining a "sensitizer" to decrease its cumulative dosage. In this study, it was investigated whether ocotillol could enhance the antiproliferation activity of Dox. MTT assays and xenograft tumor model were firstly conducted to evaluate the effect of ocotillol on the antitumor activity of Dox. Flow cytometry and Hoechst staining assays were then performed to assess cell apoptosis. Western blot and real-time PCR were finally used to detect the expression of p53 and its target genes. Our results showed ocotillol to enhance Dox-induced cell death in p53 wild-type cancer cells. Compared with Dox alone, Dox with ocotillol (Dox-O) could induce much more cell apoptosis and activate p53 to a much greater degree, which in turn markedly increased expression of proapoptosis genes. The enhanced cytotoxic activity was partially blocked by pifithrin-α, which might be through attenuating the increased apoptosis. Furthermore, ocotillol significantly increased the antitumor activity of Dox in A549 xenograft tumor in nude mice. These findings indicated that ocotillol could potentiate the cytotoxic effect of Dox through p53-dependent apoptosis and suggested that coadministration of ocotillol with Dox might be a potential therapeutic strategy. [ABSTRACT FROM AUTHOR]